Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Charts for Quick CASH $$$ -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (5433)	12/23/1997 12:48:00 AM
From: John McCarthy	Read Replies (1) \| Respond to of 9262

Hi Richard, Just lurking about and caught your comment about NMPS. I want you to know that NMPS is selling at least 1 Bladder kit a quarter! What you wrote scared me a little bit, so I'd appreciate your un-sugar coated opinion on something. I've hung with it, not because of Bayer but because of the Colon kit. They might get an A-Okay on it by the end of March. I thought (dangerous) that there would be a fair size market for this JUST given the size of the Colon Cancer patient #'s. And I further thought (extra dangerous) that they had a leg up on anything out there now in discoverying (sp?) it early. Sure would appreciate your 2 cents. Regards, John McCarthy

To: scaram(o)uche who wrote (5433)	12/23/1997 1:42:00 AM
From: John Metcalf	Respond to of 9262

I regret to report that Mr. Market Cap got creamed by DEPO, too. Entirely blindsided. Numbers for Matritech (NMPS) are mostly correct. They're burning $9mm at the run rate and have $12.9mm in cash-and-equivalents. Market cap is $66mm (18.542 shares). SEPR and ARQL are saving the day for me. ARQL began a nice move up today, and good news is anticipated with regard to their lead position at the Hambrecht & Quist conference. I look forward to seeing ARRS and SQNA on the STO. They've sold off on news of their merger and it seems overdone. The merged company (Axys) is on the H&Q agenda. ARIA is selling at a very low valuation for a high-quality company. Market cap is $76mm, and they have $33mm in cash. Burn is about $10.7mm and they have major backing from HMR for their new Genomics Institute. ARIA will hit the STO someday....